Biosciences Research and Commercialization Center (BRCC)
2026-09-01wmich.edu
Overview
What they do
The BRCC, established in 2003 by the Michigan Legislature, is located at Western Michigan University and is perfectly positioned to access the wealth of scientific talent and pharmaceutical commercialization expertise that is part of Kalamazoo’s heritage. Long-time home to such industry giants as the Upjohn Co., Richard-Allan Scientific, Stryker Corp. and Pfizer Inc., Kalamazoo offers a forward-looking, entrepreneurial business climate and a growing reputation among venture capitalists seeking to invest in life sciences discoveries and promising business ventures. Their customers are entrepreneurs, scientists, University Technology Transfer offices and corporate clients.
The BRCC provides startup and gap funding to promising Michigan-based life sciences and medical device ventures entering the commercialization phase of development.
wmich.edu
What they look for
The BRCC focuses on life sciences broadly defined to encompass pharmaceuticals, medical devices and diagnostics. Eligible companies must have a substantial presence or business link to the State of Michigan. The BRCC is required by legislation to structure any funding with the potential to achieve a return on its investment.
wmich.edu
Stage
Pre-seed, Seed
wmich.edu
Sectors
Healthcare, Food and agriculture, Climate
wmich.edu
Based
Kalamazoo, US
wmich.edu
Sources
Portfolio, cheque size and the rest
The 6 companies they have backed that we can see, the cheque they write, and whether they are deploying right now.
Start free, no cardFree accounts see every record.